Prudential Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.59M Sell
29,575
-43
-0.1% -$7.51K 0.01% 878
2025
Q4
$5.04M Sell
29,618
-10,017
-25% -$1.54M 0.01% 908
2025
Q3
$5.22M Buy
39,635
+5,780
+17% +$693K 0.01% 917
2025
Q2
$4.07M Buy
33,855
+19,660
+138% +$2.14M 0.01% 1031
2025
Q1
$1.73M Buy
14,195
+2,700
+23% +$352K ﹤0.01% 1343
2024
Q4
$1.4M Sell
11,495
-9,761
-46% -$1.15M ﹤0.01% 1448
2024
Q3
$2.37M Sell
21,256
-29,750
-58% -$3.26M ﹤0.01% 1400
2024
Q2
$5.44M Buy
51,006
+7,316
+17% +$804K 0.01% 887
2024
Q1
$5.26M Buy
43,690
+3,640
+9% +$446K 0.01% 905
2023
Q4
$4.93M Sell
40,050
-15,807
-28% -$1.97M 0.01% 939
2023
Q3
$7.23M Buy
55,857
+739
+1% +$98.5K 0.01% 758
2023
Q2
$6.83M Sell
55,118
-19,916
-27% -$2.68M 0.01% 778
2023
Q1
$11M Sell
75,034
-37,496
-33% -$5.55M 0.02% 610
2022
Q4
$17.9M Sell
112,530
-198,853
-64% -$29.1M 0.03% 453
2022
Q3
$41.5M Buy
311,383
+303,256
+3,731% +$46.1M 0.07% 263
2022
Q2
$1.27M Buy
8,127
+563
+7% +$86.7K ﹤0.01% 1655
2022
Q1
$1.18M Sell
7,564
-17,700
-70% -$2.57M ﹤0.01% 1802
2021
Q4
$3.37M Buy
25,264
+18,772
+289% +$2.47M ﹤0.01% 1251
2021
Q3
$865K Sell
6,492
-4,679
-42% -$707K ﹤0.01% 1889
2021
Q2
$1.98M Sell
11,171
-48,396
-81% -$8.38M ﹤0.01% 1484
2021
Q1
$9.79M Sell
59,567
-1,406
-2% -$231K 0.01% 770
2020
Q4
$10.1M Buy
60,973
+18,596
+44% +$2.77M 0.02% 738
2020
Q3
$6.04M Sell
42,377
-5,123
-11% -$635K 0.01% 858
2020
Q2
$5.24M Buy
47,500
+7,339
+18% +$812K 0.01% 937
2020
Q1
$4.01M Sell
40,161
-28,260
-41% -$3.65M 0.01% 1009
2019
Q4
$10.2M Sell
68,421
-68,786
-50% -$9.36M 0.02% 854
2019
Q3
$17.6M Buy
137,207
+12,144
+10% +$1.63M 0.03% 599
2019
Q2
$17.8M Buy
125,063
+95,146
+318% +$12.8M 0.03% 609
2019
Q1
$4.28M Buy
29,917
+27,323
+1,053% +$3.56M 0.01% 1203
2018
Q4
$322K Buy
2,594
+501
+24% +$74.3K ﹤0.01% 2123
2018
Q3
$352K Buy
2,093
+115
+6% +$19.8K ﹤0.01% 2138
2018
Q2
$340K Buy
+1,978
New +$323K ﹤0.01% 2159
2017
Q2
Sell
-25,067
Closed -$3.64M 2366
2017
Q1
$3.64M Sell
25,067
-416,463
-94% -$54.2M 0.01% 1275
2016
Q4
$48.1M Sell
441,530
-115,018
-21% -$12.8M 0.08% 284
2016
Q3
$67.6M Sell
556,548
-63,849
-10% -$8.61M 0.11% 197
2016
Q2
$87.7M Buy
620,397
+12,320
+2% +$1.82M 0.15% 155
2016
Q1
$79.4M Buy
608,077
+200,560
+49% +$25M 0.14% 163
2015
Q4
$57.3M Buy
407,517
+273,450
+204% +$37.9M 0.1% 203
2015
Q3
$17.8M Buy
134,067
+24,522
+22% +$4.22M 0.04% 520
2015
Q2
$19.3M Buy
109,545
+32,550
+42% +$5.85M 0.03% 560
2015
Q1
$13.3M Sell
76,995
-14,100
-15% -$2.42M 0.02% 718
2014
Q4
$14.9M Sell
91,095
-25,230
-22% -$4.19M 0.03% 584
2014
Q3
$18.7M Sell
116,325
-47,340
-29% -$7.28M 0.04% 500
2014
Q2
$24.1M Sell
163,665
-310,570
-65% -$43.1M 0.04% 431
2014
Q1
$65.8M Sell
474,235
-38,710
-8% -$5.83M 0.12% 173
2013
Q4
$64.9M Buy
512,945
+17,640
+4% +$1.83M 0.13% 171
2013
Q3
$45.6M Buy
495,305
+186,990
+61% +$15.1M 0.1% 213
2013
Q2
$21.2M Buy
+308,315
New +$18.8M 0.05% 392

Other funds holding JAZZ

Prudential Financial's JAZZ Position: Q1 2026 in Review

Prudential Financial reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.15% in Q1 2026, selling an estimated $7.51K and leaving 29,575 shares worth $5.59M. The position accounts for 0.01% of the portfolio, ranked #878.

Prudential Financial first reported a position in JAZZ in Q2 2013 and has held it in 48 quarters since. The position peaked at $87.7M in Q2 2016. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Prudential Financial held 29,575 shares of Jazz Pharmaceuticals worth $5.59M as of Q1 2026.
  • Prudential Financial sold 43 Jazz Pharmaceuticals shares in Q1 2026, an estimated $7.51K.
  • Jazz Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q1 2026, its #878 holding.
  • Prudential Financial first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • Prudential Financial's Jazz Pharmaceuticals position peaked at $87.7M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.